Global Non- Alcoholic Steatohepatitis Treatment Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-non-alcoholic-steatohepatitis-treatment-market-research-report-2024status-n-outlook_en.gif)
Report Overview
This report provides a deep insight into the global Non- Alcoholic Steatohepatitis Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non- Alcoholic Steatohepatitis Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non- Alcoholic Steatohepatitis Treatment market in any manner.
Global Non- Alcoholic Steatohepatitis Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Gilead Sciences
Bristol Myers Squibb
Novo Nordisk
NGM Biopharmaceuticals
Galectin Therapeutics
Inventiva Pharma
Intercept Pharmaceuticals
AbbVie
Madrigal Pharmaceuticals
Market Segmentation (by Type)
Cenicriviroc
Aramchol
Resmetirom
Semaglutide
Lanifibranor
Obeticholic Acid (OCA)
Market Segmentation (by Application)
Retail & Specialty Pharmacies
Hospital Pharmacies
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non- Alcoholic Steatohepatitis Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Non- Alcoholic Steatohepatitis Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non- Alcoholic Steatohepatitis Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non- Alcoholic Steatohepatitis Treatment market in any manner.
Global Non- Alcoholic Steatohepatitis Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Gilead Sciences
Bristol Myers Squibb
Novo Nordisk
NGM Biopharmaceuticals
Galectin Therapeutics
Inventiva Pharma
Intercept Pharmaceuticals
AbbVie
Madrigal Pharmaceuticals
Market Segmentation (by Type)
Cenicriviroc
Aramchol
Resmetirom
Semaglutide
Lanifibranor
Obeticholic Acid (OCA)
Market Segmentation (by Application)
Retail & Specialty Pharmacies
Hospital Pharmacies
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Non- Alcoholic Steatohepatitis Treatment Market
- Overview of the regional outlook of the Non- Alcoholic Steatohepatitis Treatment Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non- Alcoholic Steatohepatitis Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Non- Alcoholic Steatohepatitis Treatment
1.2 Key Market Segments
1.2.1 Non- Alcoholic Steatohepatitis Treatment Segment by Type
1.2.2 Non- Alcoholic Steatohepatitis Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Non- Alcoholic Steatohepatitis Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Non- Alcoholic Steatohepatitis Treatment Sales by Manufacturers (2019-2024)
3.2 Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Non- Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non- Alcoholic Steatohepatitis Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non- Alcoholic Steatohepatitis Treatment Sales Sites, Area Served, Product Type
3.6 Non- Alcoholic Steatohepatitis Treatment Market Competitive Situation and Trends
3.6.1 Non- Alcoholic Steatohepatitis Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non- Alcoholic Steatohepatitis Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Non- Alcoholic Steatohepatitis Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Type (2019-2024)
6.3 Global Non- Alcoholic Steatohepatitis Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Non- Alcoholic Steatohepatitis Treatment Price by Type (2019-2024)
7 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non- Alcoholic Steatohepatitis Treatment Market Sales by Application (2019-2024)
7.3 Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Non- Alcoholic Steatohepatitis Treatment Sales Growth Rate by Application (2019-2024)
8 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Non- Alcoholic Steatohepatitis Treatment Sales by Region
8.1.1 Global Non- Alcoholic Steatohepatitis Treatment Sales by Region
8.1.2 Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Non- Alcoholic Steatohepatitis Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non- Alcoholic Steatohepatitis Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non- Alcoholic Steatohepatitis Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non- Alcoholic Steatohepatitis Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Gilead Sciences
9.1.1 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Basic Information
9.1.2 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Product Overview
9.1.3 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.1.4 Gilead Sciences Business Overview
9.1.5 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
9.1.6 Gilead Sciences Recent Developments
9.2 Bristol Myers Squibb
9.2.1 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Basic Information
9.2.2 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Product Overview
9.2.3 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.2.4 Bristol Myers Squibb Business Overview
9.2.5 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
9.2.6 Bristol Myers Squibb Recent Developments
9.3 Novo Nordisk
9.3.1 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Basic Information
9.3.2 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Product Overview
9.3.3 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.3.4 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
9.3.5 Novo Nordisk Business Overview
9.3.6 Novo Nordisk Recent Developments
9.4 NGM Biopharmaceuticals
9.4.1 NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
9.4.2 NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
9.4.3 NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.4.4 NGM Biopharmaceuticals Business Overview
9.4.5 NGM Biopharmaceuticals Recent Developments
9.5 Galectin Therapeutics
9.5.1 Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Basic Information
9.5.2 Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Product Overview
9.5.3 Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.5.4 Galectin Therapeutics Business Overview
9.5.5 Galectin Therapeutics Recent Developments
9.6 Inventiva Pharma
9.6.1 Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Basic Information
9.6.2 Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Product Overview
9.6.3 Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.6.4 Inventiva Pharma Business Overview
9.6.5 Inventiva Pharma Recent Developments
9.7 Intercept Pharmaceuticals
9.7.1 Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
9.7.2 Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
9.7.3 Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.7.4 Intercept Pharmaceuticals Business Overview
9.7.5 Intercept Pharmaceuticals Recent Developments
9.8 AbbVie
9.8.1 AbbVie Non- Alcoholic Steatohepatitis Treatment Basic Information
9.8.2 AbbVie Non- Alcoholic Steatohepatitis Treatment Product Overview
9.8.3 AbbVie Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.8.4 AbbVie Business Overview
9.8.5 AbbVie Recent Developments
9.9 Madrigal Pharmaceuticals
9.9.1 Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
9.9.2 Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
9.9.3 Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.9.4 Madrigal Pharmaceuticals Business Overview
9.9.5 Madrigal Pharmaceuticals Recent Developments
10 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET FORECAST BY REGION
10.1 Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast
10.2 Global Non- Alcoholic Steatohepatitis Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Region
10.2.4 South America Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non- Alcoholic Steatohepatitis Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Non- Alcoholic Steatohepatitis Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Non- Alcoholic Steatohepatitis Treatment by Type (2025-2030)
11.1.2 Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Non- Alcoholic Steatohepatitis Treatment by Type (2025-2030)
11.2 Global Non- Alcoholic Steatohepatitis Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) Forecast by Application
11.2.2 Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Non- Alcoholic Steatohepatitis Treatment
1.2 Key Market Segments
1.2.1 Non- Alcoholic Steatohepatitis Treatment Segment by Type
1.2.2 Non- Alcoholic Steatohepatitis Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Non- Alcoholic Steatohepatitis Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Non- Alcoholic Steatohepatitis Treatment Sales by Manufacturers (2019-2024)
3.2 Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Non- Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non- Alcoholic Steatohepatitis Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non- Alcoholic Steatohepatitis Treatment Sales Sites, Area Served, Product Type
3.6 Non- Alcoholic Steatohepatitis Treatment Market Competitive Situation and Trends
3.6.1 Non- Alcoholic Steatohepatitis Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non- Alcoholic Steatohepatitis Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Non- Alcoholic Steatohepatitis Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Type (2019-2024)
6.3 Global Non- Alcoholic Steatohepatitis Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Non- Alcoholic Steatohepatitis Treatment Price by Type (2019-2024)
7 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non- Alcoholic Steatohepatitis Treatment Market Sales by Application (2019-2024)
7.3 Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Non- Alcoholic Steatohepatitis Treatment Sales Growth Rate by Application (2019-2024)
8 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Non- Alcoholic Steatohepatitis Treatment Sales by Region
8.1.1 Global Non- Alcoholic Steatohepatitis Treatment Sales by Region
8.1.2 Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Non- Alcoholic Steatohepatitis Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non- Alcoholic Steatohepatitis Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non- Alcoholic Steatohepatitis Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non- Alcoholic Steatohepatitis Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Gilead Sciences
9.1.1 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Basic Information
9.1.2 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Product Overview
9.1.3 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.1.4 Gilead Sciences Business Overview
9.1.5 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
9.1.6 Gilead Sciences Recent Developments
9.2 Bristol Myers Squibb
9.2.1 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Basic Information
9.2.2 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Product Overview
9.2.3 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.2.4 Bristol Myers Squibb Business Overview
9.2.5 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
9.2.6 Bristol Myers Squibb Recent Developments
9.3 Novo Nordisk
9.3.1 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Basic Information
9.3.2 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Product Overview
9.3.3 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.3.4 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
9.3.5 Novo Nordisk Business Overview
9.3.6 Novo Nordisk Recent Developments
9.4 NGM Biopharmaceuticals
9.4.1 NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
9.4.2 NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
9.4.3 NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.4.4 NGM Biopharmaceuticals Business Overview
9.4.5 NGM Biopharmaceuticals Recent Developments
9.5 Galectin Therapeutics
9.5.1 Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Basic Information
9.5.2 Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Product Overview
9.5.3 Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.5.4 Galectin Therapeutics Business Overview
9.5.5 Galectin Therapeutics Recent Developments
9.6 Inventiva Pharma
9.6.1 Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Basic Information
9.6.2 Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Product Overview
9.6.3 Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.6.4 Inventiva Pharma Business Overview
9.6.5 Inventiva Pharma Recent Developments
9.7 Intercept Pharmaceuticals
9.7.1 Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
9.7.2 Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
9.7.3 Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.7.4 Intercept Pharmaceuticals Business Overview
9.7.5 Intercept Pharmaceuticals Recent Developments
9.8 AbbVie
9.8.1 AbbVie Non- Alcoholic Steatohepatitis Treatment Basic Information
9.8.2 AbbVie Non- Alcoholic Steatohepatitis Treatment Product Overview
9.8.3 AbbVie Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.8.4 AbbVie Business Overview
9.8.5 AbbVie Recent Developments
9.9 Madrigal Pharmaceuticals
9.9.1 Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
9.9.2 Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
9.9.3 Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Market Performance
9.9.4 Madrigal Pharmaceuticals Business Overview
9.9.5 Madrigal Pharmaceuticals Recent Developments
10 NON- ALCOHOLIC STEATOHEPATITIS TREATMENT MARKET FORECAST BY REGION
10.1 Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast
10.2 Global Non- Alcoholic Steatohepatitis Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Region
10.2.4 South America Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non- Alcoholic Steatohepatitis Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Non- Alcoholic Steatohepatitis Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Non- Alcoholic Steatohepatitis Treatment by Type (2025-2030)
11.1.2 Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Non- Alcoholic Steatohepatitis Treatment by Type (2025-2030)
11.2 Global Non- Alcoholic Steatohepatitis Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) Forecast by Application
11.2.2 Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non- Alcoholic Steatohepatitis Treatment Market Size Comparison by Region (M USD)
Table 5. Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non- Alcoholic Steatohepatitis Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non- Alcoholic Steatohepatitis Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non- Alcoholic Steatohepatitis Treatment as of 2022)
Table 10. Global Market Non- Alcoholic Steatohepatitis Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non- Alcoholic Steatohepatitis Treatment Sales Sites and Area Served
Table 12. Manufacturers Non- Alcoholic Steatohepatitis Treatment Product Type
Table 13. Global Non- Alcoholic Steatohepatitis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non- Alcoholic Steatohepatitis Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non- Alcoholic Steatohepatitis Treatment Market Challenges
Table 22. Global Non- Alcoholic Steatohepatitis Treatment Sales by Type (K Units)
Table 23. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Type (M USD)
Table 24. Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Non- Alcoholic Steatohepatitis Treatment Market Size Share by Type (2019-2024)
Table 28. Global Non- Alcoholic Steatohepatitis Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) by Application
Table 30. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Application
Table 31. Global Non- Alcoholic Steatohepatitis Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Non- Alcoholic Steatohepatitis Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2024)
Table 35. Global Non- Alcoholic Steatohepatitis Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Non- Alcoholic Steatohepatitis Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Non- Alcoholic Steatohepatitis Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Non- Alcoholic Steatohepatitis Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Non- Alcoholic Steatohepatitis Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Non- Alcoholic Steatohepatitis Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Sales by Region (2019-2024) & (K Units)
Table 43. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 44. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 45. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Gilead Sciences Business Overview
Table 47. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
Table 48. Gilead Sciences Recent Developments
Table 49. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 50. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 51. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bristol Myers Squibb Business Overview
Table 53. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
Table 54. Bristol Myers Squibb Recent Developments
Table 55. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 56. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 57. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
Table 59. Novo Nordisk Business Overview
Table 60. Novo Nordisk Recent Developments
Table 61. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 62. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 63. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. NGM Biopharmaceuticals Business Overview
Table 65. NGM Biopharmaceuticals Recent Developments
Table 66. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 67. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 68. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Galectin Therapeutics Business Overview
Table 70. Galectin Therapeutics Recent Developments
Table 71. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 72. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 73. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Inventiva Pharma Business Overview
Table 75. Inventiva Pharma Recent Developments
Table 76. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 77. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 78. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Intercept Pharmaceuticals Business Overview
Table 80. Intercept Pharmaceuticals Recent Developments
Table 81. AbbVie Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 82. AbbVie Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 83. AbbVie Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. AbbVie Business Overview
Table 85. AbbVie Recent Developments
Table 86. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 87. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 88. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Madrigal Pharmaceuticals Business Overview
Table 90. Madrigal Pharmaceuticals Recent Developments
Table 91. Global Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Non- Alcoholic Steatohepatitis Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non- Alcoholic Steatohepatitis Treatment Market Size Comparison by Region (M USD)
Table 5. Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non- Alcoholic Steatohepatitis Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non- Alcoholic Steatohepatitis Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non- Alcoholic Steatohepatitis Treatment as of 2022)
Table 10. Global Market Non- Alcoholic Steatohepatitis Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non- Alcoholic Steatohepatitis Treatment Sales Sites and Area Served
Table 12. Manufacturers Non- Alcoholic Steatohepatitis Treatment Product Type
Table 13. Global Non- Alcoholic Steatohepatitis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non- Alcoholic Steatohepatitis Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non- Alcoholic Steatohepatitis Treatment Market Challenges
Table 22. Global Non- Alcoholic Steatohepatitis Treatment Sales by Type (K Units)
Table 23. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Type (M USD)
Table 24. Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Non- Alcoholic Steatohepatitis Treatment Market Size Share by Type (2019-2024)
Table 28. Global Non- Alcoholic Steatohepatitis Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) by Application
Table 30. Global Non- Alcoholic Steatohepatitis Treatment Market Size by Application
Table 31. Global Non- Alcoholic Steatohepatitis Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Non- Alcoholic Steatohepatitis Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2024)
Table 35. Global Non- Alcoholic Steatohepatitis Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Non- Alcoholic Steatohepatitis Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Non- Alcoholic Steatohepatitis Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Non- Alcoholic Steatohepatitis Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Non- Alcoholic Steatohepatitis Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Non- Alcoholic Steatohepatitis Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Sales by Region (2019-2024) & (K Units)
Table 43. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 44. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 45. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Gilead Sciences Business Overview
Table 47. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
Table 48. Gilead Sciences Recent Developments
Table 49. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 50. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 51. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bristol Myers Squibb Business Overview
Table 53. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
Table 54. Bristol Myers Squibb Recent Developments
Table 55. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 56. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 57. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment SWOT Analysis
Table 59. Novo Nordisk Business Overview
Table 60. Novo Nordisk Recent Developments
Table 61. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 62. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 63. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. NGM Biopharmaceuticals Business Overview
Table 65. NGM Biopharmaceuticals Recent Developments
Table 66. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 67. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 68. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Galectin Therapeutics Business Overview
Table 70. Galectin Therapeutics Recent Developments
Table 71. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 72. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 73. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Inventiva Pharma Business Overview
Table 75. Inventiva Pharma Recent Developments
Table 76. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 77. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 78. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Intercept Pharmaceuticals Business Overview
Table 80. Intercept Pharmaceuticals Recent Developments
Table 81. AbbVie Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 82. AbbVie Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 83. AbbVie Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. AbbVie Business Overview
Table 85. AbbVie Recent Developments
Table 86. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Basic Information
Table 87. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Overview
Table 88. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Madrigal Pharmaceuticals Business Overview
Table 90. Madrigal Pharmaceuticals Recent Developments
Table 91. Global Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Non- Alcoholic Steatohepatitis Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Non- Alcoholic Steatohepatitis Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD), 2019-2030
Figure 5. Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non- Alcoholic Steatohepatitis Treatment Market Size by Country (M USD)
Figure 11. Non- Alcoholic Steatohepatitis Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Non- Alcoholic Steatohepatitis Treatment Revenue Share by Manufacturers in 2023
Figure 13. Non- Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non- Alcoholic Steatohepatitis Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non- Alcoholic Steatohepatitis Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Type
Figure 18. Sales Market Share of Non- Alcoholic Steatohepatitis Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Non- Alcoholic Steatohepatitis Treatment by Type in 2023
Figure 20. Market Size Share of Non- Alcoholic Steatohepatitis Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Non- Alcoholic Steatohepatitis Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Application
Figure 24. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Application in 2023
Figure 26. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2024)
Figure 27. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Application in 2023
Figure 28. Global Non- Alcoholic Steatohepatitis Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Non- Alcoholic Steatohepatitis Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Non- Alcoholic Steatohepatitis Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Country in 2023
Figure 37. Germany Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Region in 2023
Figure 44. China Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (K Units)
Figure 50. South America Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Non- Alcoholic Steatohepatitis Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Non- Alcoholic Steatohepatitis Treatment Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Non- Alcoholic Steatohepatitis Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD), 2019-2030
Figure 5. Global Non- Alcoholic Steatohepatitis Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Non- Alcoholic Steatohepatitis Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non- Alcoholic Steatohepatitis Treatment Market Size by Country (M USD)
Figure 11. Non- Alcoholic Steatohepatitis Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Non- Alcoholic Steatohepatitis Treatment Revenue Share by Manufacturers in 2023
Figure 13. Non- Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non- Alcoholic Steatohepatitis Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non- Alcoholic Steatohepatitis Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Type
Figure 18. Sales Market Share of Non- Alcoholic Steatohepatitis Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Non- Alcoholic Steatohepatitis Treatment by Type in 2023
Figure 20. Market Size Share of Non- Alcoholic Steatohepatitis Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Non- Alcoholic Steatohepatitis Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Application
Figure 24. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Application in 2023
Figure 26. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Application (2019-2024)
Figure 27. Global Non- Alcoholic Steatohepatitis Treatment Market Share by Application in 2023
Figure 28. Global Non- Alcoholic Steatohepatitis Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Non- Alcoholic Steatohepatitis Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Non- Alcoholic Steatohepatitis Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Country in 2023
Figure 37. Germany Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Region in 2023
Figure 44. China Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (K Units)
Figure 50. South America Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Non- Alcoholic Steatohepatitis Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Non- Alcoholic Steatohepatitis Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Non- Alcoholic Steatohepatitis Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Non- Alcoholic Steatohepatitis Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Non- Alcoholic Steatohepatitis Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Non- Alcoholic Steatohepatitis Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Non- Alcoholic Steatohepatitis Treatment Market Share Forecast by Application (2025-2030)